Treatment of Subacute Bacterial Endocarditis Following Cardiac Catheter RFA

Immediate Diagnostic and Empirical Management

The European Society of Cardiology recommends initiating empirical therapy with vancomycin plus gentamicin plus ceftriaxone (or ampicillin-sulbactam) to cover staphylococci, streptococci, enterococci, and HACEK organisms, then tailor therapy based on blood culture results for 4-6 weeks 1, 2
Obtain three sets of blood cultures at 30-minute intervals before initiating antibiotics, with at least one set percutaneously and one from any indwelling catheter if present 1, 3

For methicillin-susceptible Staphylococcus aureus, the American Heart Association recommends nafcillin or oxacillin 12 g/24 hours IV in 4-6 divided doses for 4-6 weeks, with gentamicin 3 mg/kg/day IV for the first 3-5 days 1, 2
For enterococci, the Infectious Diseases Society of America recommends ampicillin 12 g/24 hours IV in 4-6 divided doses PLUS gentamicin 3 mg/kg/day IV for 4-6 weeks 1, 2

The European Society of Cardiology recommends treating native valve endocarditis for 4 weeks and prosthetic valve endocarditis for 6 weeks for most organisms 1, 2
Extended duration (4-6 weeks) is recommended if positive blood cultures persist ≥72 hours after catheter removal, TEE shows vegetations, or there are metastatic complications 4, 3, 9

Repeat blood cultures 2-4 days after therapy initiation to document clearance, and monitor aminoglycoside levels and renal function 4, 5, 1, 2

Urgent surgical consultation is recommended if heart failure develops, there is uncontrolled infection despite optimal antimicrobial therapy, or there are recurrent embolic events 1, 2